Axsome Therapeutics, Inc. (0HKF.L)
USD 94.11
(0.14%)
USD 94.11
(0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 270.6 Million | 50.03 Million | - | - | - | - |
| Cost of Revenue | 26.06 Million | 5.19 Million | 1.15 Million | 77.71 Thousand | 37.33 Thousand | 48.93 Thousand |
| Gross Profit | 244.53 Million | 44.83 Million | -1.15 Million | -77.71 Thousand | -37.33 Thousand | -48.93 Thousand |
| Operating Expenses | 476.36 Million | 221.34 Million | 124.7 Million | 99.08 Million | 67.1 Million | 32.62 Million |
| Selling, General and Administrative Expenses | 323.12 Million | 159.25 Million | 66.64 Million | 28.89 Million | 13.59 Million | 9.35 Million |
| Research and Development Expenses | 97.94 Million | 57.94 Million | 58.06 Million | 70.24 Million | 53.64 Million | 23.49 Million |
| Other Expenses | 55.29 Million | 4.13 Million | - | -53.57 Thousand | -139.44 Thousand | 217.41 Thousand |
| Cost and Expenses | 502.42 Million | 226.53 Million | 124.7 Million | 99.08 Million | 67.1 Million | 32.62 Million |
| Operating Income | -231.82 Million | -176.5 Million | -124.7 Million | -99.14 Million | -67.24 Million | -32.84 Million |
| Interest Expense | 6.45 Million | 7.33 Million | 5.69 Million | 2.56 Million | 1.23 Million | 1.12 Million |
| Income Tax Expense | 960 Thousand | 10.63 Million | 4.54 Million | 2.48 Million | 1.34 Million | 3 Million |
| Earnings before Tax | -238.27 Million | -187.13 Million | -130.4 Million | -102.9 Million | -68.34 Million | -30.96 Million |
| Net Income | -239.23 Million | -197.76 Million | -134.94 Million | -105.38 Million | -69.68 Million | -30.96 Million |
| Earnings Per Share Basic | -5.27 | -4.86 | -3.59 | -2.83 | -2.05 | -1.15 |
| Earnings Per Share Diluted | -5.27 | -4.86 | -3.59 | -2.83 | -2.05 | -1.15 |
| Weighted Average Shares Outstanding | 45.42 Million | 40.65 Million | 37.61 Million | 37.2 Million | 34.02 Million | 26.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.42 Million | 40.65 Million | 37.61 Million | 37.2 Million | 34.02 Million | 26.88 Million |
| Gross Margin | 0.90 | 0.90 | - | - | - | - |
| EBIT Margin | -0.83 | -3.42 | - | - | - | - |
| Profit Margin | -0.88 | -3.95 | - | - | - | - |
| EBITDA | -224.99 Million | -174.23 Million | -123.55 Million | -99.06 Million | -67.2 Million | -32.58 Million |
| Earnings Before Tax Margin | -0.86 | -3.53 | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 87.16 Million | 74.99 Million | 71.53 Million | 270.6 Million | 57.79 Million | 46.7 Million |
| Cost of Revenue | 9.9 Million | 8.12 Million | 7.37 Million | 32.89 Million | 6.53 Million | 4.59 Million |
| Gross Profit | 77.25 Million | 66.87 Million | 64.15 Million | 237.7 Million | 51.26 Million | 42.1 Million |
| Operating Expenses | 153.14 Million | 135.55 Million | 168.31 Million | 420.6 Million | 113.38 Million | 101.1 Million |
| Selling, General and Administrative Expenses | 103.55 Million | 98.97 Million | 86.8 Million | - | 83.18 Million | 78.93 Million |
| Research and Development Expenses | 49.59 Million | 36.58 Million | 30.8 Million | - | 28.76 Million | 20.58 Million |
| Other Expenses | 3.75 Million | 177 Thousand | 50.7 Million | 55.29 Million | 1.42 Million | 7.64 Million |
| Cost and Expenses | 163.05 Million | 143.68 Million | 175.69 Million | 453.5 Million | 119.91 Million | 105.7 Million |
| Operating Income | -75.88 Million | -68.68 Million | -98.11 Million | -182.9 Million | -62.12 Million | -65.05 Million |
| Interest Expense | 1.29 Million | 1.08 Million | -10.69 Million | 6.45 Million | -757 Thousand | 2.73 Million |
| Income Tax Expense | - | 1.00 | -3.6 Million | 960 Thousand | 678 Thousand | -617 Thousand |
| Earnings before Tax | -79.34 Million | -68.35 Million | -98.97 Million | -238.27 Million | -62.87 Million | -67.78 Million |
| Net Income | -79.34 Million | -68.35 Million | -98.65 Million | -239.23 Million | -62.19 Million | -67.17 Million |
| Earnings Per Share Basic | -1.67 | -1.44 | -2.08 | - | -1.32 | -1.54 |
| Earnings Per Share Diluted | -1.67 | -1.44 | -2.08 | - | -1.32 | -1.54 |
| Weighted Average Shares Outstanding | 47.57 Million | 47.39 Million | 47.32 Million | 45.42 Million | 47.11 Million | 43.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 47.57 Million | 47.39 Million | 47.32 Million | 45.42 Million | 47.11 Million | 43.66 Million |
| Gross Margin | 0.89 | 0.89 | 0.90 | 0.88 | 0.89 | 0.90 |
| EBIT Margin | -0.85 | -0.89 | -1.65 | - | -1.07 | -1.23 |
| Profit Margin | -0.91 | -0.91 | -1.38 | -0.88 | -1.08 | -1.44 |
| EBITDA | -74.03 Million | -66.85 Million | -117.71 Million | - | -62.12 Million | -57.41 Million |
| Earnings Before Tax Margin | -0.87 | -0.92 | -1.37 | -0.68 | -1.07 | -1.39 |
SAIA
SICALLOG
ZEEMEDIA
SUPERTEX
MKEXIM
0YCP